Bokhari Syed Ali, Karaman Mariam J, Thalitaya Madhusudan Deepak
Psychiatry, Al Amal Psychiatric Hospital, Emirates Health Services, Dubai, ARE.
Psychiatry, Maudsley Health, Al Amal Psychiatric Hospital, Dubai, ARE.
Cureus. 2024 Nov 28;16(11):e74661. doi: 10.7759/cureus.74661. eCollection 2024 Nov.
Schizophrenia is a chronic psychiatric disorder marked by severe disturbances in thought, perception, and behavior. Long-acting injectable (LAI) antipsychotics, such as paliperidone, are widely used to promote sustained remission and ensure medication adherence, especially in patients prone to relapse. However, the COVID-19 pandemic has introduced unique challenges, with studies indicating that infections like COVID-19 may exacerbate psychiatric symptoms through neuroinflammatory pathways. This report presents the case of Ms. X, a 48-year-old Emirati female patient with chronic schizophrenia, who achieved long-term stability on paliperidone LAI at 150 mg monthly. For almost two years, she remained stable with notable improvements in delusional and paranoid symptoms, supported by structured therapeutic care, supportive psychotherapy, occupational therapy, and family involvement. However, in August 2024, Ms. X contracted COVID-19, which triggered a sudden relapse marked by acute persecutory delusions, heightened suspicion, and avoidance behavior, despite ongoing adherence to her LAI regimen. Following her recovery from COVID-19, Ms. X's psychotic symptoms remitted without changes to her antipsychotic treatment, and she returned to her baseline functioning. This case highlights the sensitivity of chronic schizophrenia to physiological stressors such as viral infections, underscoring the importance of vigilant monitoring and comprehensive care during periods of illness. It also contributes to the growing body of evidence suggesting that infections can induce transient yet significant psychiatric relapses in otherwise stable schizophrenia patients, emphasizing the intricate interplay between physical and mental health. This case underscores the complex interplay between physical and mental health in schizophrenia and highlights the need for further research into infection-induced psychiatric exacerbations.
精神分裂症是一种慢性精神疾病,其特征是思维、感知和行为严重紊乱。长效注射用(LAI)抗精神病药物,如帕利哌酮,被广泛用于促进持续缓解并确保药物依从性,尤其是在容易复发的患者中。然而,新冠疫情带来了独特的挑战,研究表明,像新冠这样的感染可能通过神经炎症途径加剧精神症状。本报告介绍了X女士的病例,她是一名48岁的阿联酋女性慢性精神分裂症患者,每月使用150毫克长效帕利哌酮后病情长期稳定。在结构化治疗护理、支持性心理治疗、职业治疗和家庭参与的支持下,近两年来,她病情稳定,妄想和偏执症状有显著改善。然而,2024年8月,X女士感染了新冠,尽管她持续坚持长效注射药物治疗方案,但仍引发了突然复发,表现为急性迫害妄想、高度怀疑和回避行为。新冠康复后,X女士的精神症状缓解,抗精神病治疗未改变,她恢复到了基线功能水平。该病例凸显了慢性精神分裂症对病毒感染等生理应激源的敏感性,强调了患病期间进行密切监测和全面护理的重要性。它也为越来越多的证据做出了贡献,表明感染可在原本病情稳定的精神分裂症患者中诱发短暂但显著的精神复发,强调了身心健康之间复杂的相互作用。该病例强调了精神分裂症中身心健康之间复杂的相互作用,并突出了对感染诱发的精神症状加重进行进一步研究的必要性。